Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]
Exact Sciences (NASDAQ:EXAS) Announces Earnings Results, Beats Expectations By $0.26 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price objective decreased by analysts at Canaccord Genuity Group from $100.00 to $90.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. Canaccord Genuity Group’s price target would suggest a potential upside of 50.18% […]
StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report issued on Saturday. The brokerage issued a hold rating on the technology company’s stock. Separately, HC Wainwright dropped their price target on Applied DNA Sciences from $2.00 to $1.50 and set a buy rating for the company in a […]
Exact Sciences (EXAS) Scheduled to Post Quarterly Earnings on Wednesday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.